All In Biotech

Drug Trial Radar · NCT06046443

A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity

A Randomized, Placebo-controlled, Double-Blind Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity, With an Open-Label Extension

Last checked: Nov 19, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

28

Actual

Start

Jul 11, 2024

Primary completion

Feb 9, 2026

Study completion Feb 9, 2026

Sponsor

Lead sponsor
Rhythm Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Sep 21, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study was to determine how well LB54640 (also known as bivamelagon) worked and how safe it was in participants with Hypothalamic Obesity (HO). The study evaluated the effect of bivamelagon on safety, weight reduction, hunger, and quality of life in participants 12 years of age and older with HO. Participants took an oral daily dose of either bivamelagon (low, middle, or high dose) or placebo through Week 14. Eligible participants who consented to continue in the study after Week 14 took an oral daily dose of bivamelagon through Week 52.

Conditions

  • Hypothalamic Obesity

Interventions

  • BivamelagonDrug

    Oral daily administration

  • PlaceboDrug

    Placebo matched to LB54640

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Treatment Phase: Mean Percentage Change From Baseline to Week 14 in Body Mass Index (BMI)Time frame: Baseline, Week 14

Locations

10 sites in 2 countries. Site status is shown where the registry gives one.

  • Children's Hospital Colorado

    Aurora, Colorado

  • University of Iowa Children's Hospital

    Iowa City, Iowa

  • Tufts Medical Center

    Boston, Massachusetts

  • Columbia University

    New York, New York

  • The University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina

  • Lynn Health Science Institute

    Oklahoma City, Oklahoma

  • St. Jude Children's Research Hospital

    Memphis, Tennessee

  • Birmingham Women's and Children's NHS Foundation Trust

    Birmingham, United Kingdom

  • University of Cambridge

    Cambridge, United Kingdom

  • Great Ormond Street Hospital for Children

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.